
    
      Single dose safety and tolerability study: evaluate safety and tolerability of intravenous
      infusion nemonoxacin 25mg, 50mg, 125mg, 250mg, 500mg, 750mg, 1000mg and 1250mg.

      Single dose pharmacokinetic (PK) study:evaluate PK profile of doses of 250mg, 500mg or 750mg
      intravenous infusion nemonoxacin .

      Multiple dose study: evaluate PK profile of doses of 500mg, 650mg or 750mg intravenous
      infusion nemonoxacin after consecutive 10 days.
    
  